1742-4690

Retrovirology

Springer (Biomed Central Ltd.)

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 4538 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact4538 DOIs
2

Add abstracts to 3829 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact3829 DOIs
3

Deposit reference lists for 2931 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact2931 DOIs

DOIs for this ISSN

Showing the top 5 of 4727 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 HIV-1 Vif, APOBEC, and Intrinsic Immunity (10.1186/1742-4690-5-51)
Abstract References ORCID License
244.25 276
2 Integrase and integration: biochemical activities of HIV-1 i… (10.1186/1742-4690-5-114)
Abstract References ORCID License
225.53 179
3 The control of viral infection by tripartite motif proteins… (10.1186/1742-4690-4-40)
Abstract References ORCID License
225.04 177
4 HIV-1 Nef: at the crossroads (10.1186/1742-4690-5-84)
Abstract References ORCID License
217.03 147
5 Expression of infectious murine leukemia viruses by RAW264.7… (10.1186/1742-4690-5-1)
Abstract References ORCID License
215.84 143
6 Common principles and intermediates of viral protein-mediate… (10.1186/1742-4690-5-111)
Abstract References ORCID License
215.84 143
7 Host factors influencing susceptibility to HIV infection and… (10.1186/1742-4690-4-52)
Abstract References ORCID License
200.00 99
8 Compartmentalization of the gut viral reservoir in HIV-1 inf… (10.1186/1742-4690-4-87)
Abstract References ORCID License
198.68 96
9 MicroRNA miR-146a and further oncogenesis-related cellular m… (10.1186/1742-4690-5-100)
Abstract References ORCID License
195.90 90
10 Socioeconomic status (SES) as a determinant of adherence to… (10.1186/1742-4690-5-13)
Abstract References ORCID License
192.43 83
11 Identifying HIV-1 dual infections (10.1186/1742-4690-4-67)
Abstract References ORCID License
191.91 82
12 Classification and characterization of human endogenous retr… (10.1186/s12977-015-0232-y)
Abstract ORCID License
184.57 288
13 Host proteins interacting with the Moloney murine leukemia v… (10.1186/1742-4690-5-48)
Abstract References ORCID License
183.25 67
14 In-Silico docking of HIV-1 integrase inhibitors reveals a no… (10.1186/1742-4690-4-21)
Abstract References ORCID License
177.09 58
15 Pathogenicity and immunogenicity of attenuated, nef-deleted… (10.1186/1742-4690-4-66)
Abstract References ORCID License
177.09 58
16 Mechanisms of HIV non-progression; robust and sustained CD4+… (10.1186/1742-4690-5-112)
Abstract References ORCID License
176.34 57
17 Turning up the volume on mutational pressure: Is more of a g… (10.1186/1742-4690-5-26)
Abstract References ORCID License
176.34 57
18 Rapid inflammasome activation in microglia contributes to br… (10.1186/1742-4690-11-35)
Abstract ORCID License
175.83 220
19 Rapid spread of mouse mammary tumor virus in cultured human… (10.1186/1742-4690-4-73)
Abstract References ORCID License
175.59 56
20 Optimal design and validation of antiviral siRNA for targeti… (10.1186/1742-4690-4-80)
Abstract References ORCID License
167.21 46
21 Apoptosis resistance in HIV-1 persistently-infected cells is… (10.1186/1742-4690-5-19)
Abstract References ORCID License
167.21 46
22 APOBEC3G encapsidation into HIV-1 virions: which RNA is it? (10.1186/1742-4690-5-55)
Abstract References ORCID License
166.28 45
23 Sequential emergence and clinical implications of viral muta… (10.1186/1742-4690-4-25)
Abstract References ORCID License
165.32 44
24 The HIV RNA setpoint theory revisited (10.1186/1742-4690-4-65)
Abstract References ORCID License
165.32 44
25 Biphasic decay kinetics suggest progressive slowing in turno… (10.1186/1742-4690-5-107)
Abstract References ORCID License
165.32 44
26 Cofilin activation in peripheral CD4 T cells of HIV-1 infect… (10.1186/1742-4690-5-95)
Abstract References ORCID License
163.35 42
27 Differential binding of neutralizing and non-neutralizing an… (10.1186/1742-4690-11-41)
Abstract ORCID License
162.55 146
28 Early steps of retrovirus replicative cycle (10.1186/1742-4690-1-9)
Abstract ORCID License
161.65 142
29 (10.1186/1742-4690-4-7)
Abstract References ORCID License
161.28 40
30 The carbohydrate at asparagine 386 on HIV-1 gp120 is not ess… (10.1186/1742-4690-5-10)
Abstract References ORCID License
161.28 40
31 The incidence of multidrug and full class resistance in HIV-… (10.1186/1742-4690-5-12)
Abstract References ORCID License
156.82 36
32 HIV Nef and Vpu protect HIV-infected CD4+ T cells from antib… (10.1186/1742-4690-11-15)
Abstract ORCID License
155.39 117
33 Human immunodeficiency virus integrase inhibitors efficientl… (10.1186/1742-4690-4-79)
Abstract References ORCID License
154.41 34
34 A new genotype of bovine leukemia virus in South America ide… (10.1186/s12977-016-0239-z)
Abstract ORCID License
149.34 97
35 H-index, mentoring-index, highly-cited and highly-accessed:… (10.1186/1742-4690-5-106)
Abstract References ORCID License
149.14 30
36 New insights into the heterogeneity of Th17 subsets contribu… (10.1186/s12977-016-0293-6)
Abstract ORCID License
148.67 95
37 Mortality associated with HIV-1, HIV-2, and HTLV-I single an… (10.1186/1742-4690-4-85)
Abstract References ORCID License
147.71 29
38 A formylpeptide receptor, FPRL1, acts as an efficient corece… (10.1186/1742-4690-5-52)
Abstract References ORCID License
147.71 29
39 HIV-1 gene expression: lessons from provirus and non-integra… (10.1186/1742-4690-1-13)
Abstract ORCID License
146.57 89
40 A novel HIV-1-encoded microRNA enhances its viral replicatio… (10.1186/1742-4690-11-23)
Abstract ORCID License
145.84 87
41 microRNAs in viral oncogenesis (10.1186/1742-4690-4-82)
Abstract References ORCID License
144.72 27
42 New and old complex recombinant HIV-1 strains among patients… (10.1186/1742-4690-5-69)
Abstract References ORCID License
144.72 27
43 Latent HIV-1 is activated by exosomes from cells infected wi… (10.1186/s12977-015-0216-y)
Abstract ORCID License
143.54 81
44 Persistence of attenuated HIV-1 rev alleles in an epidemiolo… (10.1186/1742-4690-4-43)
Abstract References ORCID License
143.14 26
45 Human T Lymphotropic Virus Type 1 protein Tax reduces histon… (10.1186/1742-4690-5-9)
Abstract References ORCID License
143.14 26
46 HIV-1 capsid uncoating initiates after the first strand tran… (10.1186/s12977-016-0292-7)
Abstract ORCID License
143.14 80
47 Retrotransposons shape species-specific embryonic stem cell… (10.1186/s12977-015-0173-5)
Abstract ORCID License
142.73 79
48 Impact factor, H index, peer comparisons, and Retrovirology:… (10.1186/1742-4690-4-42)
Abstract References ORCID License
141.50 25
49 Design of a trans protease lentiviral packaging system that… (10.1186/1742-4690-4-96)
Abstract References ORCID License
141.50 25
50 Caspase-3-mediated cleavage of p65/RelA results in a carboxy… (10.1186/1742-4690-5-109)
Abstract References ORCID License
141.50 25